The DEA Could Reclassify Cannabis To A Less Restrictive Category
October 20, 2024
A drug policy expert weighs the pros and cons of reclassifying marijuana
A drug policy expert weighs the pros and cons of reclassifying marijuana
Speaking of the “Magic Mushroom” chocolate bars in question, store management said, “[the DEA] … had done their own lab testing on the products and some … did not pass their standards.”
“The scientific evidence in favor of removing cannabis from Schedule I remains overwhelming.”
Many investors and researchers have been predicting a psychedelics boom, with MDMA being just the first of a number of psychedelics in the drug development pipeline.
“The jury is no longer out on marijuana: It has medical uses and is currently being used for medical purposes.”
“Nurses have long known through their own first hand experience working with patients that cannabis holds legitimate therapeutic value.”
The federal comment portal is still open for nearly two months—here’s how you can submit comments on cannabis reclassification
“It’s time for Congress to wake up,” New York Sen. Chuck Schumer said, regarding changes to cannabis laws.
Most national cannabis coverage is generic, so we asked local and regional stakeholders to get specific about the potential impact of rescheduling
Sen. Cory Booker urged fellow lawmakers to “follow the lead of states around the country and legalize cannabis for adult use and create a comprehensive taxation and regulatory scheme.”
